The estimated Net Worth of Richard J Berman is at least 3.51 百万$ dollars as of 15 May 2024. Mr. Berman owns over 8,105 units of CryoPort Inc stock worth over 779,000$ and over the last 19 years he sold CYRX stock worth over 2,316,247$. In addition, he makes 411,408$ as Lead Independent Director at CryoPort Inc.
Richard has made over 27 trades of the CryoPort Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently he sold 8,105 units of CYRX stock worth 108,688$ on 15 May 2024.
The largest trade he's ever made was selling 760,624 units of CryoPort Inc stock on 12 February 2010 worth over 121,700$. On average, Richard trades about 25,600 units every 71 days since 2005. As of 15 May 2024 he still owns at least 100,000 units of CryoPort Inc stock.
You can see the complete history of Mr. Berman stock trades at the bottom of the page.
Richard J. Berman J.D. serves as Lead Independent Director of the Company. Mr. Berman became a member of our board of directors in January 2015 and serves as Chairman of the Audit Committee and member of the Compensation Committee and Nomination and Governance Committee of our board of directors. Mr. Berman’s business career spans over 35 years of venture capital, senior management and merger & acquisitions experience. Mr. Berman has served as a director and/or officer of over a dozen public and private companies. From 2006 to 2011, he was Chairman of National Investment Managers, a company with $12 billion in pension administration assets. Mr. Berman is a director of four publicly traded healthcare companies: Advaxis, Inc., Catasys, Inc., Cryoport Inc. and Immuron Limited. From 2002 to 2010, he was a director of Nexmed Inc. where he also served as Chairman/CEO in 2008 and 2009 (formerly Apricus Biosciences, Inc.); From 1998 to 2000, he was employed by Internet Commerce Corporation (now Easylink Services) as Chairman and CEO, and was a director from 1998 to 2012. Previously, Mr. Berman worked at Goldman Sachs; was Senior Vice President of Bankers Trust Company, where he started the M&A and Leveraged Buyout Departments; created the largest battery company in the world in the 1980’s by merging Prestolite, General Battery and Exide to form Exide Technologies (XIDE); helped to create what is now Soho (NYC) by developing five buildings; and advised on over $4 billion of M&A transactions. He is a past Director of the Stern School of Business of NYU where he obtained his BS and MBA. He also has U.S. and foreign law degrees from Boston College and The Hague Academy of International Law, respectively.
As the Lead Independent Director of CryoPort Inc, the total compensation of Richard Berman at CryoPort Inc is 411,408$. There are 5 executives at CryoPort Inc getting paid more, with Jerrell Shelton having the highest compensation of 3,839,460$.
Richard Berman is 77, he's been the Lead Independent Director of CryoPort Inc since 2015. There are no older and 9 younger executives at CryoPort Inc.
Richard's mailing address filed with the SEC is 2001 MARKET STREET, SUITE 3915, UNIT #15, PHILADELPHIA, PA, 19103.
Over the last 12 years, insiders at CryoPort Inc have traded over 202,268,038$ worth of CryoPort Inc stock and bought 80,292 units worth 196,910$ . The most active insiders traders include Holdings Ii L.P.Blackstone ...、Richard J Berman、Jerrell Shelton. On average, CryoPort Inc executives and independent directors trade stock every 39 days with the average trade being worth of 414,958$. The most recent stock trade was executed by Robert J Hariri on 19 August 2024, trading 1,000 units of CYRX stock currently worth 9,470$.
cryoport delivers an innovative and complete outsourced frozen shipping solution for biological materials. this breakthrough combination replaces outdated dry ice shipping, virtually eliminates the risk of cell degradation and revolutionizes deep frozen logistics. we combine the technology of liquid nitrogen dry vapor shippers with the most advanced logistics management platform in the industry. when added with our logistics expertise, we provide a complete outsourced solution that advances deep-frozen shipping for the life science community. whether your business is bio-pharmaceuticals, clinical trials, research or reproductive medicine, you want to focus on your core mission. cryoport will help you transport life.
CryoPort Inc executives and other stock owners filed with the SEC include: